| About the Center / Research Projects
 
  Our animal imaging center was
 established in 2006 with the funding
 from the Science and Technology
 Promotion Bureau of MEXT.
 Detection of metastatic cancer and
 the monitoring of therapeutic drug
 effects in animal models are the
 primary projects currently ongoing
 at this facility. Xenogen In-Vivo
 Imaging System (IVIS), which detects
 emissions from luciferase and other
 fluorescent proteins, has been in
 operation to analyze models for liver
 cancer, malignant mesothelioma, and
 prostatic cancer. A CT scanner, which
 is expected to offer more accurate
 3-D information, will be introduced
 some time this year.
 
 
 Role within ICONT
 
 The animal imaging center is the main
 facility of ICONT’s nanobio project.
 The highly sensitive and accurate in
 vivo imaging equipment is essential
 for the development of successful
 targeted therapy. Indispensable for all
 of the nanobio-related projects
 (cancer gene therapy using viral
 vectors and non-viral vectors including
 polymer, researches for bacterial biofilm,
 etc.) at ICONT, the facility is expected
 to become one of the main imaging
  facilities for exploratory medical research
 in Japan.
 
 
 Address  2-5-1, Shikata-cho, Okayama 700-8558, Japan
 
 |